Orangutan Gaming Private Limited announced that it will issue up to 1,000,000 compulsorily convertible preferred shares at a price of INR 10 per share for gross proceeds of INR 10,000,000 on May 28, 2022. The transaction will include participation from Aspira Pathlab & Diagnostics Limited. The transaction has been approved by board of directors of the investor.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
31.46 INR | +1.48% | +7.70% | -19.70% |
05-28 | Aspira Pathlab & Diagnostics Limited Reports Earnings Results for the Full Year Ended March 31, 2024 | CI |
04-03 | Aspira Pathlab Forms New Limited Liability Partnership | MT |
1st Jan change | Capi. | |
---|---|---|
-19.70% | 3.82M | |
-24.66% | 7.76B | |
+68.65% | 4.33B | |
-3.33% | 2.64B | |
+3.74% | 2.63B | |
-46.17% | 2.16B | |
-15.27% | 1.75B | |
-22.12% | 1.46B | |
+13.62% | 1.17B | |
-43.81% | 1.14B |
- Stock Market
- Equities
- ASPIRA Stock
- News Aspira Pathlab & Diagnostics Limited
- Orangutan Gaming Private Limited announced that it expects to receive INR 10 million in funding from Aspira Pathlab & Diagnostics Limited